Inhibitors of CASD1 might be useful to target sialic acid O-acetylation in cancer to facilitate GD3-mediated apoptosis, to trigger immune inhibitory Siglec signaling in autoimmunity, or to increase the immunogenicity of capsular sialic acids in bacteria. The gene discussed is CASD1; the disease is cancer.